Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of the drug following reports of encephalitus in Europe.
For information on rights and reprints, contact subscriptions@lawyerly.com.au